Diabetes

The FDA has granted 510(k) clearance for an insulin patch pump for adults with type 1 or type 2 diabetes, Embecta Corp. announced.

Pregnant women with diabetes can use automated insulin delivery systems with settings optimized to achieve tight glycemic targets, according to two speakers at the Association of Diabetes Care and Education Specialists annual meeting.

Canagliflozin may reduce albuminuria and patient-specific eGFR decline in patients with type 2 diabetes and microalbuminuria, researchers found in a parallel, open-labeled trial.

Results from two studies found no association between the use of GLP-1 receptor agonists and increased risk for suicide, suicidal thoughts or depression, findings published in JAMA Internal Medicine showed.

The Cardiometabolic Health Congress announced that Peter Libby, MD, one of the foremost authorities in atherosclerosis, will deliver the keynote address at its upcoming 19th annual conference.

More than one-third of older adults with diabetes lack the digital tools necessary for virtual diabetes self-management education, and providers can play a role in promoting digital inclusion, according to a speaker.

Both HbA1c and continuous glucose monitoring metrics have limitations, and providers should not rely on a single metric for managing a patient’s diabetes, according to two speakers.

Women with fetal overgrowth or hypertensive disorders of pregnancy have notable continuous glucose monitor-derived glycemic patterns detected during early pregnancy, sometimes without a gestational diabetes diagnosis, researchers reported.

Researchers estimate that semaglutide 2.4 mg is not cost-effective for secondary CVD prevention for patients with overweight or obesity without diabetes, according to an Australian study.

Care partners of deaf and hard-of-hearing people with diabetes face several communication-related challenges that could be addressed through a specialized training program, according to two presenters.